Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer, March 2018

Free Subscription


Abstracts

Retrieve all available abstracts of the following 196 articles:
HTML format


 

Single Articles

  1. TOLIMAN PJ, Kaldor JM, Tabrizi SN, Vallely AJ, et al
    Innovative approaches to cervical cancer screening in low- and middle-income countries.
    Climacteric. 2018 Feb 28:1-4. doi: 10.1080/13697137.2018.1439917.
    Abstract    

    Abstract available

  2. FU L, Cheng A, Sun M, Wang X, et al
    [Value of (18)F-FDG PET-CT in detection of primary lesion and pelvic lymph node metastasis in FIGO stages A2-A cervical cancer].
    Zhejiang Da Xue Xue Bao Yi Xue Ban. 2017;46:517-522.
    Abstract    

    Abstract available

  3. TAN D, Zhou C, Han S, Hou X, et al
    MicroRNA-378 enhances migration and invasion in cervical cancer by directly targeting autophagy-related protein 12.
    Mol Med Rep. 2018 Feb 27. doi: 10.3892/mmr.2018.8645.
    Abstract    

    Abstract available

  4. INUI K, Nakagawa Y, Hasegawa G, Ikeda Y, et al
    Urothelial carcinoma with sarcomatous variant of the bladder following radiotherapy for cervical cancer: A case report.
    Urol Case Rep. 2018;17:125-127.
    Abstract    



  5. WANG L, Shen H, Zhu D, Feng B, et al
    Increased high mobility group A 2 expression promotes transition of cervical intraepithelial neoplasm into cervical cancer.
    Oncotarget. 2018;9:7891-7901.
    Abstract    

    Abstract available

  6. TAN SC, Ismail MP, Duski DR, Othman NH, et al
    Prevalence and type distribution of human papillomavirus (HPV) in Malaysian women with and without cervical cancer: an updated estimate.
    Biosci Rep. 2018 Feb 27. pii: BSR20171268. doi: 10.1042/BSR20171268.
    Abstract    

    Abstract available

  7. ZHU Y, Han Y, Tian T, Su P, et al
    MiR-21-5p, miR-34a, and human telomerase RNA component as surrogate markers for cervical cancer progression.
    Pathol Res Pract. 2018 Jan 9. pii: S0344-0338(17)31013.
    Abstract    

    Abstract available

  8. CHATTERJEE K, AlSharif D, Mazza C, Syar P, et al
    Resveratrol and Pterostilbene Exhibit Anticancer Properties Involving the Downregulation of HPV Oncoprotein E6 in Cervical Cancer Cells.
    Nutrients. 2018;10.
    Abstract    

    Abstract available

  9. GUO M, Huang E, Liu X, Tang Y, et al
    Volumetric Modulated Arc Therapy versus Fixed-Field Intensity-Modulated Radiotherapy in Radical Irradiation for Cervical Cancer without Lymphadenectasis: Dosimetric and Clinical Results.
    Oncol Res Treat. 2018;41:105-109.
    Abstract    

    Abstract available

  10. SCOLNICK EM
    A vaccine to prevent cervical cancer: academic and industrial collaboration and a Lasker award.
    Clin Transl Immunology. 2017;7:e1002.
    Abstract    



  11. YANG D, Zhang W, Liang J, Ma K, et al
    Single cell whole genome sequencing reveals that NFKB1 mutation affects radiotherapy sensitivity in cervical cancer.
    Oncotarget. 2017;9:7332-7340.
    Abstract    

    Abstract available

  12. LIN J, Hu W, Gao F, Qin J, et al
    Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer.
    J Cancer. 2018;9:564-577.
    Abstract    

    Abstract available

  13. VISWANATHAN C, Faria S, Devine C, Patnana M, et al
    [18F]-2-Fluoro-2-Deoxy-D-glucose-PET Assessment of Cervical Cancer.
    PET Clin. 2018;13:165-177.
    Abstract    

    Abstract available

  14. EBU NI, Ogah JK
    Predictors of cervical cancer screening intention of HIV-positive women in the central region of Ghana.
    BMC Womens Health. 2018;18:43.
    Abstract    

    Abstract available

  15. REFAEI M, Dehghan Nayeri N, Khakbazan Z, Yazdkhasti M, et al
    Exploring Effective Contextual Factors for Regular Cervical Cancer Screening in Iranian Women: A Qualitative Study
    Asian Pac J Cancer Prev. 2018;19:533-539.
    Abstract    

    Abstract available

  16. WANG X, Sheu JJ, Lai MT, Yin-Yi Chang C, et al
    RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer.
    Biomedicine (Taipei). 2018;8:4.
    Abstract    

    Abstract available

  17. DAS D, Sarkar B, Mukhopadhyay S, Banerjee C, et al
    An Altered Ratio of CD4+ And CD8+ T Lymphocytes in Cervical Cancer Tissues and Peripheral Blood - A Prognostic Clue?
    Asian Pac J Cancer Prev. 2018;19:471-478.
    Abstract    

    Abstract available

  18. PHUTHONG S, Settheetham-Ishida W, Natphopsuk S, Ishida T, et al
    Genetic Polymorphism of the Glutathione S-transferase Pi 1 (GSTP1) and Susceptibility to Cervical Cancer in Human Papilloma Virus Infected Northeastern Thai Women
    Asian Pac J Cancer Prev. 2018;19:381-385.
    Abstract    

    Abstract available

  19. NARTEY Y, Hill PC, Amo-Antwi K, Nyarko KM, et al
    Characteristics of Women Diagnosed with Invasive Cervical Cancer in Ghana
    Asian Pac J Cancer Prev. 2018;19:357-363.
    Abstract    

    Abstract available

  20. SHRESTHA AD, Neupane D, Vedsted P, Kallestrup P, et al
    Cervical Cancer Prevalence, Incidence and Mortality in Low and Middle Income Countries: A Systematic Review
    Asian Pac J Cancer Prev. 2018;19:319-324.
    Abstract    

    Abstract available

  21. SANCHES J, Xu Y, Yabasin IB, Li M, et al
    miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
    Chem Biol Interact. 2018 Feb 22. pii: S0009-2797(17)31329.
    Abstract    

    Abstract available

  22. ALTAZI BA, Fernandez DC, Zhang GG, Hawkins S, et al
    Investigating multi-radiomic models for enhancing prediction power of cervical cancer treatment outcomes.
    Phys Med. 2018 Feb 20. pii: S1120-1797(17)30478.
    Abstract    

    Abstract available

  23. WASZCZUK E, Waszczuk K, Bohdanowicz-Pawlak A, Florjanski J, et al
    Women with inflammatory bowel diseases have a suboptimal cervical cancer screening rate and are not aware of the recommended human papilloma virus vaccine.
    Gynecol Endocrinol. 2018 Feb 23:1-3. doi: 10.1080/09513590.2017.1416466.
    Abstract    

    Abstract available

  24. CORDEIRO MN, de Lima RCP, Paolini F, Melo ARDS, et al
    Current research into novel therapeutic vaccines against cervical cancer.
    Expert Rev Anticancer Ther. 2018 Feb 23. doi: 10.1080/14737140.2018.1445527.
    Abstract    

    Abstract available

  25. MASSAD LS
    Anticipating the Impact of Human Papillomavirus Vaccination on US Cervical Cancer Prevention Strategies.
    J Low Genit Tract Dis. 2018 Feb 23. doi: 10.1097/LGT.0000000000000385.
    Abstract    

    Abstract available

  26. THIEL DE BOCANEGRA H, Navarro SK, Nonzee NJ, Vangala S, et al
    Trends in Cervical Cancer Screening in California's Family Planning Program.
    J Low Genit Tract Dis. 2018 Feb 28. doi: 10.1097/LGT.0000000000000376.
    Abstract    

    Abstract available

  27. ENDARTI D, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N, et al
    A Comparison of EQ-5D-3L Index Scores Using Malaysian, Singaporean, Thai, and UK Value Sets in Indonesian Cervical Cancer Patients.
    Value Health Reg Issues. 2017;15:50-55.
    Abstract    

    Abstract available

  28. OKAMOTO H, Murakami N, Carvajal CC, Miura Y, et al
    Positional uncertainty of vaginal cuff and feasibility of implementing portable bladder scanner in postoperative cervical cancer patients.
    Phys Med. 2018;45:1-5.
    Abstract    

    Abstract available

  29. HEINTZMAN J, Hatch B, Coronado G, Ezekiel D, et al
    Role of Race/Ethnicity, Language, and Insurance in Use of Cervical Cancer Prevention Services Among Low-Income Hispanic Women, 2009-2013.
    Prev Chronic Dis. 2018;15:E25.
    Abstract    

    Abstract available

  30. NARAYANA G, Suchitra MJ, Sunanda G, Ramaiah JD, et al
    Knowledge, attitude, and practice toward cervical cancer among women attending Obstetrics and Gynecology Department: A cross-sectional, hospital-based survey in South India.
    Indian J Cancer. 2017;54:481-487.
    Abstract    

    Abstract available

  31. WONGWARANGKANA C, Wanlapakorn N, Chansaenroj J, Poovorawan Y, et al
    Retinoic acid receptor beta promoter methylation and risk of cervical cancer.
    World J Virol. 2018;7:1-9.
    Abstract    

    Abstract available

  32. BAZINE A, Zniber HO, Ghaouti M, Bazine A, et al
    An Uncommon Case of Renal Metastasis from Cervical Cancer.
    Cureus. 2017;9:e1941.
    Abstract    

    Abstract available

  33. SCHWARZ TF, Galaj A, Spaczynski M, Wysocki J, et al
    Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age.
    Cancer Med. 2017;6:2723-2731.
    Abstract    

    Abstract available

  34. GUO F, Hirth JM, Berenson AB
    Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.
    J Womens Health (Larchmt). 2017;26:1114-1122.
    Abstract    

    Abstract available

  35. NEZHAT F, Falik R
    Cancer and uterine preservation: a first step toward preserving fertility after pelvic radiation.
    Fertil Steril. 2017;108:240-241.
    Abstract    



  36. HWANG JP
    Primary Cutaneous Angiosarcoma Mimicking Metastasis on 18F-FDG PET/CT in Woman With Cervix Cancer.
    Clin Nucl Med. 2017 Jun 19. doi: 10.1097/RLU.0000000000001741.
    Abstract    

    Abstract available

  37. NICCOLAI LM, Meek JI, Brackney M, Hadler JL, et al
    Declines in HPV-associated high-grade cervical lesions after introduction of HPV vaccines in Connecticut, US, 2008-2015.
    Clin Infect Dis. 2017 May 17. doi: 10.1093.
    Abstract    

    Abstract available

  38. LOO NH, Matchett G
    Use of a Tilting Orthopedic Fracture Table to Facilitate Proper Patient Positioning During Intrathecal Neurolysis With Hyperbaric Phenol: A Case Report.
    A A Case Rep. 2017;9:164-168.
    Abstract    

    Abstract available

  39. BRANSTETTER AJ, McRee AL, Reiter PL
    Correlates of Human Papillomavirus Infection Among a National Sample of Sexual Minority Women.
    J Womens Health (Larchmt). 2017;26:1004-1011.
    Abstract    

    Abstract available

  40. WANG L, Kang X, Pan D
    Gram-Scale Synthesis of Hydrophilic PEI-Coated AgInS2 Quantum Dots and Its Application in Hydrogen Peroxide/Glucose Detection and Cell Imaging.
    Inorg Chem. 2017;56:6122-6130.
    Abstract    

    Abstract available

  41. QIAN L, Xu F, Wang X, Jiang M, et al
    LncRNA expression profile of DeltaNp63alpha in cervical squamous cancers and its suppressive effects on LIF expression.
    Cytokine. 2017;96:114-122.
    Abstract    

    Abstract available

  42. WANG C, Gu W, Zhang Y, Ji Y, et al
    Nicotine promotes cervical carcinoma cell line HeLa migration and invasion by activating PI3k/Akt/NF-kappaB pathway in vitro.
    Exp Toxicol Pathol. 2017;69:402-407.
    Abstract    

    Abstract available

  43. BEST AL, Strane A, Christie O, Bynum S, et al
    Examining the Influence of Cost Concern and Awareness of Low-cost Health Care on Cancer Screening among the Medically Underserved.
    J Health Care Poor Underserved. 2017;28:79-87.
    Abstract    

    Abstract available

  44. LIU J, Lu Z, Wang G, Wang W, et al
    Viral load and integration status of HPV58 associated with cervical lesion severity in women of Northeast China.
    Jpn J Clin Oncol. 2017;47:123-129.
    Abstract    

    Abstract available

  45. AZRIELANT S, Tiosano S, Watad A, Mahroum N, et al
    Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
    Immunol Res. 2017;65:464-469.
    Abstract    

    Abstract available

  46. NOVIANTI PW, Snoek BC, Wilting SM, van de Wiel MA, et al
    Better diagnostic signatures from RNAseq data through use of auxiliary co-data.
    Bioinformatics. 2017;33:1572-1574.
    Abstract    

    Abstract available

  47. RAN J, Luo Y, Zhang Y, Yang Y, et al
    Phosphorylation of EB1 regulates the recruitment of CLIP-170 and p150glued to the plus ends of astral microtubules.
    Oncotarget. 2017;8:9858-9867.
    Abstract    

    Abstract available

  48. YANG YC, Chang TY, Chen TC, Lin WS, et al
    ITPR3 gene haplotype is associated with cervical squamous cell carcinoma risk in Taiwanese women.
    Oncotarget. 2017;8:10085-10090.
    Abstract    

    Abstract available

  49. KIM HJ, Lee SY, Kim CY, Kim YH, et al
    Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Oncotarget. 2017;8:6608-6622.
    Abstract    

    Abstract available

  50. MANDERS DB, Sims TT, Albuquerque KV, Carlson MJ, et al
    Emphasis on Systemic Therapy in Women With Pelvic Bone Metastasis at Time of Diagnosis of Cervical Cancer.
    Am J Clin Oncol. 2018 Mar 8. doi: 10.1097/COC.0000000000000439.
    Abstract    

    Abstract available

  51. ZHANG W, Wu Q, Wang C, Yang L, et al
    AKIP1 promotes angiogenesis and tumor growth by upregulating CXC-chemokines in cervical cancer cells.
    Mol Cell Biochem. 2018 Mar 8. pii: 10.1007/s11010-018-3335.
    Abstract    

    Abstract available

  52. YE H, Song T, Zeng X, Li L, et al
    Association between genital mycoplasmas infection and human papillomavirus infection, abnormal cervical cytopathology, and cervical cancer: a systematic review and meta-analysis.
    Arch Gynecol Obstet. 2018 Mar 8. pii: 10.1007/s00404-018-4733.
    Abstract    

    Abstract available

  53. ZHANG M, Shi M, Zhao Y
    Association between serum copper levels and cervical cancer risk: A meta-analysis.
    Biosci Rep. 2018 Mar 8. pii: BSR20180161. doi: 10.1042/BSR20180161.
    Abstract    

    Abstract available

  54. JIANG T, Wei D, Sha R, Zhang J, et al
    Psychological factors and demands for breast and cervical cancer screening.
    Patient Educ Couns. 2018 Feb 24. pii: S0738-3991(18)30080.
    Abstract    

    Abstract available

  55. OYERVIDES-MUNOZ MA, Perez-Maya AA, Rodriguez-Gutierrez HF, Macias GSG, et al
    Understanding the HPV integration and its progression to cervical cancer.
    Infect Genet Evol. 2018 Mar 5. pii: S1567-1348(18)30090.
    Abstract    

    Abstract available

  56. ZHAO X, Wu Q, Wang X, Fu Y, et al
    The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: A cross-sectional study in 10,669 Chinese women.
    Clin Microbiol Infect. 2018 Mar 5. pii: S1198-743X(18)30202.
    Abstract    

    Abstract available

  57. FANG SQ, Gao M, Xiong SL, Chen HY, et al
    Combining differential expression and differential coexpression analysis identifies optimal gene and gene set in cervical cancer.
    J Cancer Res Ther. 2018;14:201-207.
    Abstract    

    Abstract available

  58. ZHANG B, Chen X, Lin Y, Wang S, et al
    Occludin protein expression in human cervical cancer and its association with patient's clinical characteristics.
    J Cancer Res Ther. 2018;14:124-127.
    Abstract    

    Abstract available

  59. HU G, Zhang J, Xu F, Deng H, et al
    SLP-2 inhibits cisplatin-induced apoptosis through MEK/ERK signaling and mitochondrial apoptosis pathway in cervical cancer cells.
    Cancer Sci. 2018 Mar 8. doi: 10.1111/cas.13563.
    Abstract    

    Abstract available

  60. SONG Y, Erickson B, Chen X, Li G, et al
    Appropriate magnetic resonance imaging techniques for gross tumor volume delineation in external beam radiation therapy of locally advanced cervical cancer.
    Oncotarget. 2018;9:10100-10109.
    Abstract    

    Abstract available

  61. HU JM, Liang WH, Qi CH, Wang XL, et al
    HLA-DQB1*03 and DRB1*07 alleles increase the risk of cervical cancer among Uighur and Han women in Xinjiang, China.
    Future Oncol. 2018 Mar 7. doi: 10.2217/fon-2018-0048.
    Abstract    

    Abstract available

  62. KOWALSKA JD, Wroblewska A, Zabek P, Firlag-Burkacka E, et al
    Barriers to cervical cancer screening exist despite integrating HIV and gynaecological services for HIV-positive women in Poland.
    Ginekol Pol. 2018;89:68-73.
    Abstract    

    Abstract available

  63. SAEED M, Alshammari FD, Alam MJ, Sarim KM, et al
    A synopsis on the role of human papilloma virus infection in cervical cancer.
    Curr Drug Metab. 2018 Mar 2. pii: CDM-EPUB-88898.
    Abstract    

    Abstract available

  64. KIM SW, Lee JN, Kim HT, Yoo ES, et al
    Management of a patient with vesicocutaneous fistula presenting 13 years after radiotherapy performed for cervical cancer.
    Turk J Urol. 2018;44:185-188.
    Abstract    

    Abstract available

  65. MA HB, Yao YN, Yu JJ, Chen XX, et al
    Extensive profiling of circular RNAs and the potential regulatory role of circRNA-000284 in cell proliferation and invasion of cervical cancer via sponging miR-506.
    Am J Transl Res. 2018;10:592-604.
    Abstract    

    Abstract available

  66. SZABOOVA V, Svihrova V, Svihra J Jr, Riskova L, et al
    [Validation of a new tool for identification of barriers to cervical cancer prevention in Slovakia].
    Ceska Gynekol. 2018;83:30-35.
    Abstract    

    Abstract available

  67. COLE G, Ali AA, McCrudden CM, McBride JW, et al
    DNA vaccination for cervical cancer: Strategic optimisation of RALA mediated gene delivery from a biodegradable microneedle system.
    Eur J Pharm Biopharm. 2018 Mar 3. pii: S0939-6411(17)31334.
    Abstract    

    Abstract available

  68. LI Y, Wan YP, Bai Y
    Correlation between long strand non-coding RNA GASS expression and prognosis of cervical cancer patients.
    Eur Rev Med Pharmacol Sci. 2018;22:943-949.
    Abstract    

    Abstract available

  69. SUN R, Koubaa I, Limkin EJ, Dumas I, et al
    Locally advanced cervical cancer with bladder invasion: clinical outcomes and predictive factors for vesicovaginal fistulae.
    Oncotarget. 2018;9:9299-9310.
    Abstract    

    Abstract available

  70. WONG JPH, Vahabi M, Miholjcic J, Tan V, et al
    Knowledge of HPV/cervical cancer and acceptability of HPV self-sampling among women living with HIV: A scoping review.
    Curr Oncol. 2018;25:e73-e82.
    Abstract    

    Abstract available

  71. WOOD B, MSc, Lofters A, Vahabi M, et al
    Strategies to reach marginalized women for cervical cancer screening: A qualitative study of stakeholder perspectives.
    Curr Oncol. 2018;25:e8-e16.
    Abstract    

    Abstract available

  72. PEDERSEN HN, Smith LW, Racey CS, Cook D, et al
    Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings.
    Curr Oncol. 2018;25:e4-e7.
    Abstract    



  73. FRANCO EL
    Self-sampling for cervical cancer screening: Empowering women to lead a paradigm change in cancer control.
    Curr Oncol. 2018;25:e1-e3.
    Abstract    



  74. VAHABI M, Lofters A
    HPV self-sampling: A promising approach to reduce cervical cancer screening disparities in Canada.
    Curr Oncol. 2018;25:13-18.
    Abstract    



  75. DOU H, Yang S, Hu Y, Xu D, et al
    Sesamin induces ER stress-mediated apoptosis and activates autophagy in cervical cancer cells.
    Life Sci. 2018 Mar 2. pii: S0024-3205(18)30101-2. doi: 10.1016/j.lfs.2018.
    Abstract    

    Abstract available

  76. XU M, Zhou F, Huang L
    Concomitant endometrial and cervical adenocarcinoma: A case report and literature review.
    Medicine (Baltimore). 2018;97:e9596.
    Abstract    

    Abstract available

  77. FOUNTA C, Papagiannakis E, Ratnavelu N, Feusi A, et al
    Diagnostic accuracy of colposcopy with dynamic spectral imaging for cytology-negative/high-risk HPV positive (failed test of cure) after large loop excision of the transformation zone (LLETZ) of the cervix: Results of the DySIS colposcopy 1 study.
    Medicine (Baltimore). 2018;97:e9560.
    Abstract    

    Abstract available

  78. WANG HR, Lin Y, Zhang XY, Ma XT, et al
    Transvaginal color doppler sonography combined with colposcopy for diagnosis of early stage cervical cancer and precancerous lesions.
    J Biol Regul Homeost Agents. 2018;32:123-126.
    Abstract    

    Abstract available

  79. DIVER EJ, Hinchcliff EM, Gockley AA, Melamed A, et al
    Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old.
    J Geriatr Oncol. 2018 Mar 1. pii: S1879-4068(17)30279.
    Abstract    

    Abstract available

  80. HARDER E, Juul KE, Jensen SM, Thomsen LT, et al
    Factors associated with non-participation in cervical cancer screening - A nationwide study of nearly half a million women in Denmark.
    Prev Med. 2018 Feb 28. pii: S0091-7435(18)30072.
    Abstract    

    Abstract available

  81. EGGEMANN H, Ignatov T, Geyken CH, Seitz S, et al
    Management of elderly women with cervical cancer.
    J Cancer Res Clin Oncol. 2018 Mar 2. pii: 10.1007/s00432-018-2617.
    Abstract    

    Abstract available

  82. RAMANATHAN P, Dhandapani H, Jayakumar H, Seetharaman A, et al
    Immunotherapy for cervical cancer: Can it do another lung cancer?
    Curr Probl Cancer. 2018 Jan 6. pii: S0147-0272(17)30191.
    Abstract    

    Abstract available

  83. GARLAND SM, Giuliano A, Brotherton J, Moscicki AB, et al
    IPVS Statement Moving towards Elimination of Cervical Cancer as a Public Health Problem.
    Papillomavirus Res. 2018 Feb 27. pii: S2405-8521(18)30013.
    Abstract    



  84. MOHAMMED DY, Shukla P, Babayants Y, Sison R, et al
    Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016.
    Int J Womens Health. 2018;10:83-87.
    Abstract    

    Abstract available

  85. ZHANG W, Chen M, Cheng H, Shen Q, et al
    The role of calgranulin B gene on the biological behavior of squamous cervical cancer in vitro and in vivo.
    Cancer Manag Res. 2018;10:323-338.
    Abstract    

    Abstract available

  86. LIU XF, Li XY, Zheng PS, Yang WT, et al
    DAX1 promotes cervical cancer cell growth and tumorigenicity through activation of Wnt/beta-catenin pathway via GSK3beta.
    Cell Death Dis. 2018;9:339.
    Abstract    

    Abstract available

  87. BAEDYANANDA F, Chaiwongkot A, Bhattarakosol P
    Elevated HPV16 E1 Expression Is Associated with Cervical Cancer Progression.
    Intervirology. 2018 Mar 1. pii: 000487048. doi: 10.1159/000487048.
    Abstract    

    Abstract available

  88. JIN Y, Kim SC, Kim HJ, Ju W, et al
    Use of protein-based biomarkers of exfoliated cervical cells for primary screening of cervical cancer.
    Arch Pharm Res. 2018 Feb 28. pii: 10.1007/s12272-018-1015.
    Abstract    

    Abstract available

  89. FILIPESCU A, Balescu I, Bacalbasa N
    Upper Abdominal Resection for Isolated Metastatic Lesions in Recurrent Cervical Cancer.
    Anticancer Res. 2018;38:1659-1663.
    Abstract    

    Abstract available

  90. WANG J, Liu Q, Yang L, Xia X, et al
    Curcumin-Loaded TPGS/F127/P123 Mixed Polymeric Micelles for Cervical Cancer Therapy: Formulation, Characterization, and InVitro and InVivo Evaluation.
    J Biomed Nanotechnol. 2017;13:1631-1646.
    Abstract    

    Abstract available

  91. CRUICKSHANK M
    Treatment or surveillance for CIN2?
    BMJ. 2018;360:k771.
    Abstract    



  92. ZHANG J, Zhang Y, Zhang Z
    Association of rs2279744 and rs117039649 promoter polymorphism with the risk of gynecological cancer: A meta-analysis of case-control studies.
    Medicine (Baltimore). 2018;97:e9554.
    Abstract    

    Abstract available

  93. ZHOU J, Chen Y, Xu X, Yan D, et al
    Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB.
    Medicine (Baltimore). 2018;97:e9323.
    Abstract    

    Abstract available

  94. KANYINA EW, Kamau L, Muturi M
    Cervical precancerous changes and selected cervical microbial infections, Kiambu County, Kenya, 2014: a cross sectional study.
    BMC Infect Dis. 2017;17:647.
    Abstract    

    Abstract available

  95. BUSK M, Munk OL, Jakobsen SS, Horsman MR, et al
    Hypoxia positron emission tomography imaging: combining information on perfusion and tracer retention to improve hypoxia specificity.
    Acta Oncol. 2017;56:1583-1590.
    Abstract    

    Abstract available

  96. KIM K, Kim S, Chung Y
    A qualitative study exploring factors associated with Pap test use among North Korean refugees.
    Health Care Women Int. 2017;38:1115-1129.
    Abstract    

    Abstract available

  97. SARMADI S, Izadi-Mood N, Movarei F, Sefidbakht S, et al
    Association of Neo Angiogenesis by CD34 Expression and Clinicopathologic Features in Squamous Cell Carcinoma of Cervix.
    Acta Med Iran. 2017;55:282-289.
    Abstract    

    Abstract available

  98. JIA YY, Tan WJ, Duan FF, Pan ZM, et al
    A Genetically Modified attenuated Listeria Vaccine Expressing HPV16 E7 Kill Tumor Cells in Direct and Antigen-Specific Manner.
    Front Cell Infect Microbiol. 2017;7:279.
    Abstract    

    Abstract available

  99. DE FREITAS AC, de Oliveira THA, Barros MR Jr, Venuti A, et al
    hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
    J Exp Clin Cancer Res. 2017;36:71.
    Abstract    

    Abstract available

  100. CHU CS, Pfister DG
    Opportunities and Challenges: Human Papillomavirus and Cancer.
    J Natl Compr Canc Netw. 2017;15.
    Abstract    

    Abstract available

  101. VIENS L, Perin D, Senkomago V, Neri A, et al
    Questions About Cervical and Breast Cancer Screening Knowledge, Practice, and Outcomes: A Review of Demographic and Health Surveys.
    J Womens Health (Larchmt). 2017;26:403-412.
    Abstract    

    Abstract available

  102. RASK M, Swahnberg K, Lindell G, Oscarsson M, et al
    Women's experiences of abnormal Pap smear results - A qualitative study.
    Sex Reprod Healthc. 2017;12:3-8.
    Abstract    

    Abstract available

  103. CERASUOLO A, Annunziata C, Tortora M, Starita N, et al
    Comparative analysis of HPV16 gene expression profiles in cervical and in oropharyngeal squamous cell carcinoma.
    Oncotarget. 2017;8:34070-34081.
    Abstract    

    Abstract available

  104. TURKMEN IC, Usubutun A, Cakir A, Aydin O, et al
    What does the Data of 354,725 Patients from Turkey Tell Us About Cervical Smear Epithelial Cell Abnormalities? - The Epithelial Cell Abnormality Rate is Increasing - Quality Control Studies and Corrective Activity are Musts.
    Turk Patoloji Derg. 2017;33:134-143.
    Abstract    

    Abstract available

  105. EBU NI
    Socio-demographic characteristics influencing cervical cancer screening intention of HIV-positive women in the central region of Ghana.
    Gynecol Oncol Res Pract. 2018;5:3.
    Abstract    

    Abstract available

  106. XU L, Xu J, Hu Z, Yang B, et al
    Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 alpha genes in cervical cancer.
    Oncol Lett. 2018;15:4477-4484.
    Abstract    

    Abstract available

  107. SPINA M, Arndt J, Landau MJ, Cameron LD, et al
    Enhancing Health Message Framing With Metaphor and Cultural Values: Impact on Latinas' Cervical Cancer Screening.
    Ann Behav Med. 2018;52:106-115.
    Abstract    

    Abstract available

  108. XU SX, Lin JS, Zhan YM
    [Value of p16/Ki-67 dual-staining immunocytochemistry in cervical cancer screening].
    Zhonghua Bing Li Xue Za Zhi. 2018;47:207-208.
    Abstract    



  109. DONG J, Wang Q, Li L, Xiao-Jin Z, et al
    Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p.
    Cell Physiol Biochem. 2018;45:2086-2094.
    Abstract    

    Abstract available

  110. VAJDA R, Juhasz K, Endrei D
    Clinical and health policy experiences with HPV prevalence within the Hungarian organized cervical cancer screening program.
    J Gynecol Oncol. 2018 Mar 1. pii: 29.e45. doi: 10.3802/jgo.2018.
    Abstract    



  111. DITTO A, Bogani G, Leone Roberti Maggiore U, Martinelli F, et al
    Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer.
    J Gynecol Oncol. 2018 Feb 28. pii: 29.e41. doi: 10.3802/jgo.2018.
    Abstract    

    Abstract available

  112. SHIDA J, Kuwana K, Takahashi K
    Behavioral intention to prevent cervical cancer and related factors among female high school students in Japan.
    Jpn J Nurs Sci. 2018 Mar 13. doi: 10.1111/jjns.12205.
    Abstract    

    Abstract available

  113. BLANCAS S, Medina-Berlanga R, Ortiz-Garcia L, Loredo-Ramirez A, et al
    Protein Expression Analysis in Uterine Cervical Cancer for Potential Targets in Treatment.
    Pathol Oncol Res. 2018 Mar 12. pii: 10.1007/s12253-018-0401.
    Abstract    

    Abstract available

  114. PEPRAH S, Curreiro FC, Hayes JH, Stern K, et al
    A spatiotemporal analysis of invasive cervical cancer incidence in the state of Maryland between 2003 and 2012.
    Cancer Causes Control. 2018 Mar 12. pii: 10.1007/s10552-018-1019.
    Abstract    

    Abstract available

  115. KUMAR L, Harish P, Malik PS, Khurana S, et al
    Chemotherapy and targeted therapy in the management of cervical cancer.
    Curr Probl Cancer. 2018 Feb 3. pii: S0147-0272(18)30019.
    Abstract    

    Abstract available

  116. WANG X, Liu H, Shi L, Yu X, et al
    LINP1 facilitates DNA damage repair through non-homologous end joining (NHEJ) pathway and subsequently decreases the sensitivity of cervical cancer cells to ionizing radiation.
    Cell Cycle. 2018 Mar 12:1-31. doi: 10.1080/15384101.2018.1442625.
    Abstract    

    Abstract available

  117. HUY NVQ, Tam LM, Tram NVQ, Thuan DC, et al
    The value of visual inspection with acetic acid and Pap smear in cervical cancer screening program in low resource settings - A population-based study.
    Gynecol Oncol Rep. 2018;24:18-20.
    Abstract    

    Abstract available

  118. WATSON M, Benard V, Flagg EW
    Assessment of trends in cervical cancer screening rates using healthcare claims data: United States, 2003-2014.
    Prev Med Rep. 2018;9:124-130.
    Abstract    

    Abstract available

  119. LAZNIAK S, Lutkowska A, Warenczak-Florczak Z, Sowinska A, et al
    The association of CCAT2 rs6983267 SNP with MYC expression and progression of uterine cervical cancer in the Polish population.
    Arch Gynecol Obstet. 2018 Mar 10. pii: 10.1007/s00404-018-4740.
    Abstract    

    Abstract available

  120. DATTA GD, Blair A, Sylvestre MP, Gauvin L, et al
    Cervical cancer screening in Montreal: Building evidence to support primary care and policy interventions.
    Prev Med. 2018 Mar 7. pii: S0091-7435(18)30081.
    Abstract    

    Abstract available

  121. SONG Y, Guo Q, Gao S, Hua K, et al
    Tripartite motif-containing protein 3 plays a role of tumor inhibitor in cervical cancer.
    Biochem Biophys Res Commun. 2018 Mar 7. pii: S0006-291X(18)30520.
    Abstract    

    Abstract available


  122. Correction: Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.
    BMJ Open. 2018;8:e016700corr1.
    Abstract    



  123. YAN Q, Tian Y, Hao F
    Downregulation of lncRNA UCA1 inhibits proliferation and invasion of cervical cancer cells through miR-206 expression.
    Oncol Res. 2018 Mar 9. doi: 10.3727/096504018X15185714083446.
    Abstract    

    Abstract available

  124. YE C, Hu Y, Wang J
    MicroRNA-377 targets zinc finger E-box-binding homeobox 2 to inhibit cell proliferation and invasion of cervical cancer.
    Oncol Res. 2018 Mar 9. doi: 10.3727/096504018X15201124340860.
    Abstract    

    Abstract available

  125. KIM JH, Kim DY, Suh DS, Kim JH, et al
    The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer.
    World J Surg Oncol. 2018;16:52.
    Abstract    

    Abstract available

  126. AKA KE, Apollinaire Horo G, Fomba M, Kouyate S, et al
    A rare case of important and recurrent abnormal uterine bleeding in a post partum woman caused by cavernous hemangioma: a case report and review of literature.
    Pan Afr Med J. 2017;28:130.
    Abstract    

    Abstract available

  127. GRABOSCH SM, Shariff OM, Helm CW
    Non-steroidal anti-inflammatory agents to induce regression and prevent the progression of cervical intraepithelial neoplasia.
    Cochrane Database Syst Rev. 2018;2:CD004121.
    Abstract    

    Abstract available

  128. KAWACHI A, Yoshida H, Kitano S, Ino Y, et al
    Tumor-associated CD204(+) M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma.
    Cancer Sci. 2018;109:863-870.
    Abstract    

    Abstract available

  129. KELLY H, Mayaud P, Segondy M, Pant Pai N, et al
    A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening.
    Sex Transm Infect. 2017;93.
    Abstract    

    Abstract available

  130. LOCKLEAR TD, Doyle BJ, Perez AL, Wicks SM, et al
    Menopause in Latin America: Symptoms, attitudes, treatments and future directions in Costa Rica.
    Maturitas. 2017;104:84-89.
    Abstract    

    Abstract available

  131. FAN A, Zhang L, Wang C, Wang Y, et al
    Analysis of clinical factors correlated with the accuracy of colposcopically directed biopsy.
    Arch Gynecol Obstet. 2017;296:965-972.
    Abstract    

    Abstract available

  132. BAEZCONDE-GARBANATI L, Lienemann BA, Robles M, Johnson E, et al
    Implementation of HPV vaccination guidelines in a diverse population in Los Angeles: Results from an environmental scan of local HPV resources and needs.
    Vaccine. 2017 Jul 31. pii: S0264-410X(17)31006.
    Abstract    

    Abstract available

  133. HOPPE-SEYLER K, Mandl J, Adrian S, Kuhn BJ, et al
    Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells.
    Viruses. 2017;9.
    Abstract    

    Abstract available

  134. LIM K, van Dyk S, Khaw P, Veera J, et al
    Patterns of practice survey for brachytherapy for cervix cancer in Australia and New Zealand.
    J Med Imaging Radiat Oncol. 2017;61:674-681.
    Abstract    

    Abstract available

  135. ZHANG F, Zhang JG, Qu J, Zhang Q, et al
    Assessment of anti-cancerous potential of 6-gingerol (Tongling White Ginger) and its synergy with drugs on human cervical adenocarcinoma cells.
    Food Chem Toxicol. 2017;109.
    Abstract    

    Abstract available

  136. CHO SY, Choi M, Ban HJ, Lee CH, et al
    Cervical small cell neuroendocrine tumor mutation profiles via whole exome sequencing.
    Oncotarget. 2017;8:8095-8104.
    Abstract    

    Abstract available

  137. HIDER P, Dempster-Rivett K, Williman J, Dempster-Rivett M, et al
    A review of cervical cancer occurrences in New Zealand 2008-2012.
    N Z Med J. 2018;131:53-63.
    Abstract    

    Abstract available

  138. GUO Y, Tao M, Jiang M
    MicroRNA-454-3p inhibits cervical cancer cell invasion and migration by targeting c-Met.
    Exp Ther Med. 2018;15:2301-2306.
    Abstract    

    Abstract available

  139. SUN HY, Tang Q, Chen JH, Lv XJ, et al
    Cisplatin concurrent chemoradiotherapy vs adjuvant radiation in stage IB/IIA cervical cancer with intermediate risk factors, treated with radical surgery: a retrospective study.
    Onco Targets Ther. 2018;11:1149-1155.
    Abstract    

    Abstract available

  140. NANTHAMONGKOLKUL K, Hanprasertpong J
    Predictive Factors of Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer.
    Oncol Res Treat. 2018;41.
    Abstract    



  141. NASCIMENTO SGD, Carvalho CPAL, Silva RSD, Oliveira CM, et al
    Decline of mortality from cervical cancer.
    Rev Bras Enferm. 2018;71.
    Abstract    

    Abstract available

  142. QIN DA, Song JF, Song LP, Feng GS, et al
    Integrated approach to pain management for a patient with multiple bone metastases of uterine cervical cancer.
    J Int Med Res. 2018 Jan 1:300060518763709. doi: 10.1177/0300060518763709.
    Abstract    

    Abstract available

  143. MA Y, Zhao G, Qi J, Sun P, et al
    Neoadjuvant brachytherapy and chemotherapy followed by radical surgery for stage IB2 and IIA cervical cancer: A retrospective comparison with chemoirradiation.
    Mol Clin Oncol. 2018;8:623-627.
    Abstract    

    Abstract available

  144. SUN X, Cui M, Wang D, Guo B, et al
    Tumor necrosis factor-related apoptosis inducing ligand overexpression and Taxol treatment suppresses the growth of cervical cancer cells in vitro and in vivo.
    Oncol Lett. 2018;15:5744-5750.
    Abstract    

    Abstract available

  145. LIU Y, Fan Y, Wang X, Huang Z, et al
    Musashi-2 is a prognostic marker for the survival of patients with cervical cancer.
    Oncol Lett. 2018;15:5425-5432.
    Abstract    

    Abstract available

  146. MA L, Feng L, Ding X, Li Y, et al
    Effect of TLR4 on the growth of SiHa human cervical cancer cells via the MyD88-TRAF6-TAK1 and NF-kappaB-cyclin D1-STAT3 signaling pathways.
    Oncol Lett. 2018;15:3965-3970.
    Abstract    

    Abstract available

  147. WADA T, Fukuda T, Shimomura M, Inoue Y, et al
    XPA expression is a predictive marker of the effectiveness of neoadjuvant chemotherapy for locally advanced uterine cervical cancer.
    Oncol Lett. 2018;15:3766-3771.
    Abstract    

    Abstract available

  148. WANG N, Li Y, Zhou J
    Downregulation of ribonucleotide reductase subunits M2 induces apoptosis and G1 arrest of cervical cancer cells.
    Oncol Lett. 2018;15:3719-3725.
    Abstract    

    Abstract available

  149. ALEJO M, Alemany L, Clavero O, Quiros B, et al
    Contribution of Human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases.
    Papillomavirus Res. 2018 Mar 16. pii: S2405-8521(17)30044.
    Abstract    

    Abstract available

  150. SEQUERA VG, Mena M, Hollmann M, Mani E, et al
    IDENTIFYING POPULATIONS MOST SUSCEPTIBLE TO GET BENEFIT FROM BROADENING THE SCOPE FOR PREVENTION OF CERVICAL CANCER: EXAMPLE FROM URUGUAY.
    Papillomavirus Res. 2018 Mar 16. pii: S2405-8521(17)30052.
    Abstract    

    Abstract available

  151. SARABHAI T, Tschischka A, Stebner V, Nensa F, et al
    Simultaneous multiparametric PET/MRI for the assessment of therapeutic response to chemotherapy or concurrent chemoradiotherapy of cervical cancer patients: Preliminary results.
    Clin Imaging. 2018;49:163-168.
    Abstract    

    Abstract available

  152. PETRY KU, Bollaerts K, Bonanni P, Stanley M, et al
    Estimation of the individual residual risk of cervical cancer after vaccination with the nonavalent HPV vaccine.
    Hum Vaccin Immunother. 2018 Mar 19:1-23. doi: 10.1080/21645515.2018.1450125.
    Abstract    

    Abstract available

  153. LIU Q, Lu C, Dai W, Li K, et al
    Association of biobehavioral factors with non-coding RNAs in cervical cancer.
    Biosci Trends. 2018;12:24-31.
    Abstract    

    Abstract available

  154. KARAMANOU M, Drogosis A, Salakos N, Markatos K, et al
    Cervical cancer in the work of the unconventional Samuel Pozzi (1846-1918), pioneer of modern gynaecology.
    J BUON. 2018;23:279-285.
    Abstract    

    Abstract available

  155. QIU F, Zhao X
    Study on the sensitivity of primary tumor cells of patients with cervical cancer to chemotherapeutic combinations.
    J BUON. 2018;23:117-123.
    Abstract    

    Abstract available

  156. GUO C, Wen L, Song JK, Zeng WJ, et al
    Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis.
    Oncotarget. 2018;9:12365-12375.
    Abstract    

    Abstract available

  157. PENG J, Hou F, Feng J, Xu SX, et al
    Long non-coding RNA BCYRN1 promotes the proliferation and metastasis of cervical cancer via targeting microRNA-138 in vitro and in vivo.
    Oncol Lett. 2018;15:5809-5818.
    Abstract    

    Abstract available

  158. LI A, Gu Y, Li X, Sun H, et al
    S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway.
    Oncol Lett. 2018;15:5685-5693.
    Abstract    

    Abstract available

  159. HUANG J, Liu T, Shang C, Zhao Y, et al
    Identification of lncRNAs by microarray analysis reveals the potential role of lncRNAs in cervical cancer pathogenesis.
    Oncol Lett. 2018;15:5584-5592.
    Abstract    

    Abstract available

  160. SANKARANARAYANAN R, Joshi S, Muwonge R, Esmy PO, et al
    Can a single dose of human papillomavirus (HPV) vaccine prevent cervical cancer? Early findings from an indian study.
    Vaccine. 2018 Mar 15. pii: S0264-410X(18)30286.
    Abstract    

    Abstract available

  161. LINN YH, Thu KK, Win NHH
    Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: a Randomized Double-Blind Placebo-Controlled Study.
    Probiotics Antimicrob Proteins. 2018 Mar 17. pii: 10.1007/s12602-018-9408.
    Abstract    

    Abstract available

  162. CASTLE PE, Wheeler CM, Campos NG, Sy S, et al
    Inefficiencies of over-screening and under-screening for cervical cancer prevention in the U.S.
    Prev Med. 2018;111:177-179.
    Abstract    

    Abstract available

  163. DA ROCHA BOEIRA T, Wolf JM, Coser J, Grivicich I, et al
    Polymorphisms in Genes Related to Cervical Cancer in A Brazilian Population: A Case-Control Study.
    Pathol Oncol Res. 2018 Mar 15. pii: 10.1007/s12253-018-0414.
    Abstract    



  164. RONN MM, Turner KM
    The dawn of novel STI prevention methods: modelling potential unintended effects of changes in cervical cancer screening guidelines on trichomoniasis.
    Sex Transm Infect. 2018 Mar 15. pii: sextrans-2018-053534.
    Abstract    



  165. JIN J
    HPV Infection and Cancer.
    JAMA. 2018;319:1058.
    Abstract    



  166. CHANTZIANTONIOU N, Mukherjee M, Donnelly AD, Pantanowitz L, et al
    Digital Applications in Cytopathology: Problems, Rationalizations, and Alternative Approaches.
    Acta Cytol. 2018;62:68-76.
    Abstract    

    Abstract available

  167. GOMES DE OLIVEIRA G, Eleuterio RMN, Silveira Goncalves AK, Giraldo PC, et al
    Atypical Squamous Cells in Liquid-Based Cervical Cytology: Microbiology, Inflammatory Infiltrate, and Human Papillomavirus-DNA Testing.
    Acta Cytol. 2018;62:28-33.
    Abstract    

    Abstract available

  168. PRIGENZI KCK, Heinke T, Salim RC, Focchi GRA, et al
    Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
    Acta Cytol. 2018 Mar 22. pii: 000487504. doi: 10.1159/000487504.
    Abstract    

    Abstract available

  169. LAGHEDEN C, Eklund C, Lamin H, Kleppe SN, et al
    Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer.
    Br J Cancer. 2018 Mar 21. pii: 10.1038/s41416-018-0053.
    Abstract    

    Abstract available

  170. TRACHT J, Wrenn A, Eltoum IE
    Primary HPV testing verification: A retrospective ad-hoc analysis of screening algorithms on women doubly tested for cytology and HPV.
    Diagn Cytopathol. 2017;45:580-586.
    Abstract    

    Abstract available

  171. ZHAO PY, Jiang HC, Li Y, Wang JB, et al
    Comparison of the cervista HPV HR test and luminex XMAP technology for the diagnosis of cervical intraepithelial neoplasia.
    Eur J Obstet Gynecol Reprod Biol. 2017;214:150-155.
    Abstract    

    Abstract available

  172. GARUTTI P, Borghi C, Bedoni C, Bonaccorsi G, et al
    HPV-based strategy in follow-up of patients treated for high-grade cervical intra-epithelial neoplasia: 5-year results in a public health surveillance setting.
    Eur J Obstet Gynecol Reprod Biol. 2017;210:236-241.
    Abstract    

    Abstract available

  173. PAREJA R, Echeverri L, Rendon G, Munsell M, et al
    Radical parametrectomy after 'cut-through' hysterectomy in low-risk early-stage cervical cancer: Time to consider this procedure obsolete.
    Gynecol Oncol. 2018 Feb 23. pii: S0090-8258(18)30134.
    Abstract    

    Abstract available

  174. HARKENRIDER MM, Altoos B, Small W Jr.
    Prognostic significance of residual lymph node status after definitive chemoradiotherapy in patients with node-positive cervical cancer.
    Gynecol Oncol. 2018;148:437-438.
    Abstract    



  175. MATSUMOTO K, Yaegashi N, Iwata T, Yamamoto K, et al
    Early impact of the Japanese immunization program implemented before the HPV vaccination crisis.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30855.
    Abstract    



  176. YU L, Jiang M, Qu P, Wu Z, et al
    Clinical Evaluation of Human Papillomavirus 16/18 Oncoprotein Test for Cervical Cancer Screening and HPV Positive Women Triage.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31368.
    Abstract    

    Abstract available

  177. YOSHIHARA K, Ishiguro T, Chihara M, Shima E, et al
    The Safety and Effectiveness of Abdominal Radical Trachelectomy for Early-Stage Cervical Cancer During Pregnancy.
    Int J Gynecol Cancer. 2018 Feb 28. doi: 10.1097/IGC.0000000000001218.
    Abstract    

    Abstract available

  178. BASU P, Mehta A, Jain M, Gupta S, et al
    A Randomized Phase 2 Study of ADXS11-001 Listeria monocytogenes-Listeriolysin O Immunotherapy With or Without Cisplatin in Treatment of Advanced Cervical Cancer.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001235.
    Abstract    

    Abstract available

  179. LAIOS A, Kasius J, Tranoulis A, Gryparis A, et al
    Obstetric Outcomes in Women With Early Bulky Cervical Cancer Downstaged by Neoadjuvant Chemotherapy to Allow for Fertility-Sparing Surgery: A Meta-analysis and Metaregression.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001232.
    Abstract    

    Abstract available

  180. MINIG L, Fagotti A, Scambia G, Salvo G, et al
    Incidence of Lymph Node Metastases in Women With Low-Risk Early Cervical Cancer (<2 cm) Without Lymph-Vascular Invasion.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001236.
    Abstract    

    Abstract available

  181. PLOTTI F, Terranova C, Capriglione S, Crispino S, et al
    Assessment of Quality of Life and Urinary and Sexual Function After Radical Hysterectomy in Long-Term Cervical Cancer Survivors.
    Int J Gynecol Cancer. 2018 Mar 14. doi: 10.1097/IGC.0000000000001239.
    Abstract    

    Abstract available

  182. RYCKMAN JM, Lin C, Simone CB 2nd, Verma V, et al
    Patterns of Care for Stage IA Cervical Cancer: Use of Definitive Radiation Therapy Versus Hysterectomy.
    Int J Gynecol Cancer. 2018 Mar 20. doi: 10.1097/IGC.0000000000001225.
    Abstract    

    Abstract available

  183. KALASH R, Glaser SM, Rangaswamy B, Horne ZD, et al
    Use of Functional Magnetic Resonance Imaging in Cervical Cancer Patients With Incomplete Response on Positron Emission Tomography/Computed Tomography After Image-Based High-Dose-Rate Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2018 Feb 6. pii: S0360-3016(18)30216.
    Abstract    

    Abstract available

  184. MANEA E, Escande A, Bockel S, Khettab M, et al
    Risk of Late Urinary Complications Following Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: Refining Bladder Dose-Volume Parameters.
    Int J Radiat Oncol Biol Phys. 2018 Feb 13. pii: S0360-3016(18)30251.
    Abstract    

    Abstract available

  185. WANG KS, Lv Y, Wang Z, Ma J, et al
    Imperatorin efficiently blocks TNF-alpha-mediated activation of ROS/PI3K/Akt/NF-kappaB pathway.
    Oncol Rep. 2017;37:3397-3404.
    Abstract    

    Abstract available

  186. KEENAN LG, Rock K, Azmi A, Salib O, et al
    An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
    Radiother Oncol. 2018 Mar 6. pii: S0167-8140(18)30084.
    Abstract    

    Abstract available

  187. ZHOU Y, Hao Y, Li Y, Li R, et al
    Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.
    BMC Cancer. 2017;17:230.
    Abstract    

    Abstract available

  188. TRANBERG M, Bech BH, Blaakaer J, Jensen JS, et al
    Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
    BMC Cancer. 2018;18:273.
    Abstract    

    Abstract available

  189. SHI D, Liang Z, Zhang C, Zhang H, et al
    The effect of surgery on the survival status of patients with locally advanced cervical cancer after radiotherapy/chemoradiotherapy: a meta-analysis.
    BMC Cancer. 2018;18:308.
    Abstract    

    Abstract available

  190. HABTU Y, Yohannes S, Laelago T
    Health seeking behavior and its determinants for cervical cancer among women of childbearing age in Hossana Town, Hadiya zone, Southern Ethiopia: community based cross sectional study.
    BMC Cancer. 2018;18:298.
    Abstract    

    Abstract available

  191. TOUCH S, Oh JK
    Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    BMC Cancer. 2018;18:294.
    Abstract    

    Abstract available

  192. PALATNIK A, Ye S, Kendziorski C, Iden M, et al
    Correction: Identification of a serum-induced transcriptional signature associated with metastatic cervical cancer.
    PLoS One. 2018;13:e0193687.
    Abstract    

    Abstract available

  193. WANG W, Yue Z, Tian Z, Xie Y, et al
    Expression of Yin Yang 1 in cervical cancer and its correlation with E-cadherin expression and HPV16 E6.
    PLoS One. 2018;13:e0193340.
    Abstract    

    Abstract available

  194. LI XM, Liu J, Pan FF, Shi DD, et al
    Quercetin and aconitine synergistically induces the human cervical carcinoma HeLa cell apoptosis via endoplasmic reticulum (ER) stress pathway.
    PLoS One. 2018;13:e0191062.
    Abstract    

    Abstract available

  195. MIRI MR, Moodi M, Sharif-Zadeh GR, Malaki Moghadam H, et al
    Cognitive predictors of cervical cancer screening's stages of change among sample of Iranian women health volunteers: A path analysis.
    PLoS One. 2018;13:e0193638.
    Abstract    

    Abstract available

  196. JIN YM, Liu SS, Chen J, Chen YN, et al
    Robotic radical hysterectomy is superior to laparoscopic radical hysterectomy and open radical hysterectomy in the treatment of cervical cancer.
    PLoS One. 2018;13:e0193033.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;